Hyperfine (NASDAQ:HYPR – Get Free Report) had its target price lowered by stock analysts at B. Riley from $1.50 to $1.20 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. B. Riley’s price target indicates a potential upside of 46.34% from the stock’s previous close.
Separately, Wells Fargo & Company raised their price target on Hyperfine from $1.10 to $1.29 and gave the company an “equal weight” rating in a research note on Tuesday.
Check Out Our Latest Stock Analysis on HYPR
Hyperfine Price Performance
Hyperfine (NASDAQ:HYPR – Get Free Report) last posted its quarterly earnings results on Monday, March 17th. The company reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.02. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. The company had revenue of $2.32 million for the quarter, compared to analysts’ expectations of $2.30 million. During the same period last year, the firm earned ($0.15) earnings per share. On average, research analysts expect that Hyperfine will post -0.57 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Hyperfine
Several hedge funds have recently made changes to their positions in HYPR. Virtu Financial LLC purchased a new position in shares of Hyperfine during the fourth quarter worth about $25,000. Graypoint LLC purchased a new position in shares of Hyperfine during the fourth quarter worth about $44,000. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Hyperfine by 64.3% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock worth $72,000 after purchasing an additional 32,093 shares during the last quarter. Renaissance Technologies LLC grew its holdings in shares of Hyperfine by 32.9% during the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock worth $187,000 after purchasing an additional 52,500 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Hyperfine by 18.7% during the third quarter. Geode Capital Management LLC now owns 624,520 shares of the company’s stock worth $675,000 after purchasing an additional 98,335 shares during the last quarter. Hedge funds and other institutional investors own 15.03% of the company’s stock.
About Hyperfine
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Recommended Stories
- Five stocks we like better than Hyperfine
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- FedEx Delivers Another Crushing Blow to Its Stock Price
- 3 Small Caps With Big Return Potential
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.